Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPearson Regulatory News (PSON)

Share Price Information for Pearson (PSON)

Share Price is delayed by 15 minutes
Get Live Data
1,135.50    0.00 (0.00%)
Bid:
955.00
Ask:
0.00
Spread: 180.00 (18.848%)
Market Cap: £6.82b
PSON Live PriceLast checked at - London Stock Exchange

Intraday Pearson Share Chart

Statement re Pearson plc

30 Mar 2022 10:33

RNS Number : 5867G
Apollo Management IX, L.P.
30 March 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE")

 

FOR IMMEDIATE RELEASE

30 March 2022

 

Statement regarding Pearson plc ("Pearson")

 

Further to the announcements made by Apollo Global Management, Inc. and its subsidiaries ("Apollo"), on behalf of certain of its affiliated funds, and Pearson on 11 March 2022, Apollo notes that it has been unable to reach agreement with the board of Pearson as to the terms of an offer for the entire issued and to be issued share capital of Pearson.

 

Accordingly, Apollo confirms that it does not intend to make an offer for Pearson. This is a statement to which Rule 2.8 of the Code applies.

 

For the purposes of Rule 2.8 of the Code, Apollo, on behalf of its affiliated funds, and any person acting in concert with it, reserves the right to announce or participate in an offer or possible offer for Pearson and/or to take any other action which would otherwise be restricted under Rule 2.8 of the Code within the 6 months after the date of this announcement in the following circumstances:

 

a) with the agreement of the Board of Pearson;

 

b) following the announcement by or on behalf of a third party of a firm intention to make an offer for Pearson;

 

c) following the announcement by Pearson of a proposal for a "whitewash" (as referred to in Note 1 of the Notes on Dispensations from Rule 9 of the Code) or for a reverse takeover (as defined in the Code); or

 

d) if there has been a material change of circumstances (as determined by the Panel on Takeovers and Mergers).

 

 

Enquiries: 

 

For investor enquiries regarding Apollo, please contact:

Noah Gunn, Global Head of Investor Relations +1 212 822 0540

 

 

For media enquiries regarding Apollo, please contact:

Joanna Rose, Global Head of Corporate Communications +1 212 822 0491

 

 

Publication on website

A copy of this announcement will be made available, subject to certain restrictions relating to persons resident in restricted jurisdictions, on Apollo's website at www.apollo.com by no later than 12 noon (London time) on the business day following the date of this announcement. For the avoidance of doubt, the content of this website are not incorporated into, and do not form part of, this announcement.

About Apollo

 

Apollo is a global, high-growth alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade to private equity with a focus on three business strategies: yield, hybrid, and equity. For more than three decades, our investing expertise across our fully integrated platform has served the financial return needs of our clients and provided businesses with innovative capital solutions for growth. Through Athene, our retirement services business, we specialize in helping clients achieve financial security by providing a suite of retirement savings products and acting as a solutions provider to institutions. Our patient, creative, and knowledgeable approach to investing aligns our clients, businesses we invest in, our employees, and the communities we impact, to expand opportunity and achieve positive outcomes. As of December 31, 2021, Apollo had approximately $498 billion of assets under management. To learn more, please visit www. apollo.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFIFVAVFIIVIF
Date   Source Headline
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20264:02 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSAnnouncement of share repurchase programme
19th Jan 20267:00 amRNSHolding(s) in Company
16th Jan 202612:23 pmRNSBlock listing Interim Review
14th Jan 20267:00 amRNSPearson 2025 Trading Update: January 2026
6th Jan 20264:00 pmRNSDirector/PDMR Shareholding
2nd Jan 202610:30 amRNSTotal Voting Rights
15th Dec 20253:01 pmRNSDirector/PDMR Shareholding
12th Dec 20259:01 amRNSDirector/PDMR Shareholding
9th Dec 20258:34 amRNSHolding(s) in Company
5th Dec 202512:12 pmRNSCommittee Appointment
1st Dec 202511:00 amRNSTotal Voting Rights
1st Dec 202510:45 amRNSBlock listing Interim Review
26th Nov 20254:00 pmRNSDirector/PDMR Shareholding
26th Nov 20254:00 pmRNSHolding(s) in Company
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 202510:06 amRNSTotal Voting Rights
3rd Nov 20259:46 amRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20259:23 amRNSDirectorate Change
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20254:00 pmRNSHolding(s) in Company
17th Oct 20257:00 amRNSPearson 2025 Nine Month Trading Update
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20254:00 pmRNSAdditional Listing
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20253:45 pmRNSDirector Declaration
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.